MDB's prospects improve due to expanding partnerships and product portfolio. However, stretched valuation remains a concern for investors.
MongoDB (MDB) concluded the recent trading session at $335.40, signifying a -1.75% move from its prior day's close.
MongoDB (MDB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
The latest trading day saw MongoDB (MDB) settling at $290.04, representing a -1.39% change from its previous close.
MongoDB's Q2 fiscal 2025 revenue increased by 13% year-over-year to $478.1 million, with Atlas contributing 71% of total revenue. The NoSQL database market is projected to grow significantly, with estimates reaching up to $82.3 billion by 2031, indicating robust industry expansion. MDB faces strong competition from Amazon's DynamoDB, which offers comparable features and benefits from AWS integration.
MongoDB (MDB) closed at $271.85 in the latest trading session, marking a +0.54% move from the prior day.
MongoDB's new business remains unaffected by the macro environment, with strong new customer growth and a low market share in a large market. Existing workload consumption is impacted by macro conditions, but Atlas consumption growth exceeded expectations, contributing to a 13% year-over-year revenue increase. MongoDB's realistic approach to AI highlights long-term opportunities, with AI applications expected to benefit from MongoDB's flexible, scalable, and secure data layer.
MongoDB (MDB) reachead $268.74 at the closing of the latest trading day, reflecting a +1.98% change compared to its last close.
MongoDB CEO and president Dev Ittycheria joins 'Squawk Box' to discuss the origins of the company, transforming the New York City tech landscape, his thoughts on remote work, impact of AI technology, and more.
Cloud-based software stocks were flying high to start the year, but have undergone an extensive correction since the spring.
MDB's prospects improve due to strengthening GenAI and predictive AI applications. However, stretched valuation remains a concern for investors.